menu
    • menu

    Company profile for Juventas Cell Therapy

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Juventas Cell Therapy Ltd (hereinafter referred as to JUVENTAS) is a biopharmaceutical company established in 2018, focusing on the research and development of innovative immune cell therapy products. JUVENTAS regards clinical requirements as the lodestar, constructs innovative research pipelines, and possesses effective development transformation platforms.Through professional and sophisticated production, QA, and QC system, ...
    Juventas Cell Therapy Ltd (hereinafter referred as to JUVENTAS) is a biopharmaceutical company established in 2018, focusing on the research and development of innovative immune cell therapy products. JUVENTAS regards clinical requirements as the lodestar, constructs innovative research pipelines, and possesses effective development transformation platforms.Through professional and sophisticated production, QA, and QC system, we produce safe, highly-effective, and accessible immune cell therapy products for patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Juventas Cell TherapyChina Flag
    Country
    Country
    China
    Address
    Address
    Rm1103, China Central Place Tower 3, No.77, Jianguo Road, Chaoyang District, B...
    Telephone
    Telephone
    010-65960098
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.juventas.cn/en/index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Casi Pharma announces CNCT19 (CD19 CAR-T) granted ODD by The U.S. FDA
    Casi Pharma announces CNCT19 (CD19 CAR-T) granted ODD by The U.S. FDA

    18 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-cnct19-cd19-car-t-granted-orphan-drug-designation-by-the-us-fda-301462499.html

    PRNEWSWIRE
    18 Jan 2022
    Share Share
    Juventas Cell Therapy closes a $63M funding round
    Juventas Cell Therapy closes a $63M funding round

    25 Oct 2021

    // Ben Adams FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/juventas-cell-therapy-closes-a-63m-funding-round-as-it-eyes-a-big-push-for-blood-cancer

    Ben Adams FIERCEBIOTECH
    25 Oct 2021
    Share Share
    Juventas Cell Therapy Closes Series C Financing
    Juventas Cell Therapy Closes Series C Financing

    20 Jul 2021

    // DIGITALJOURNAL

    https://www.digitaljournal.com/pr/juventas-cell-therapy-ltd-closes-series-c-financing-to-advance-the-rapid-commercialization-and-internationalization-development-strategy

    DIGITALJOURNAL
    20 Jul 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search